An Informative Review On Cerebral Sinovenous Thrombosis
It is a rare form of venous thromboembolism mostly affecting the young people. 
It represents almost 0.5% to 3% of all the types of strokes.
- Requires a doctors intervention and medical imaging for diagnosis.
- Treatment options available
- Imaging tests required for diagnosis
Cerebral sinovenous thrombosis (CSVT) is a condition characterized by various clinical spectra, difficult diagnosis, and variable etiologies/prognosis that require fine medical skills and a high suspicious index. Prognosis depends on early detection.  Causes of clinical presentation include impaired venous drainage, intracranial hemorrhage (ICH), focal brain injury from venous ischemia/infarction and hemorrhage.  The chronic form of CSVT corresponds to 20% of cases, and the symptoms develop over a period of more than 30 days and up to 6 months. 
Self-diagnosable: It is not self-diagnosable and requires a doctors intervention and medical imaging for diagnosis.
Medical Imaging Required- Head computed tomography (CT), CT venography, magnetic resonance imaging/venography (MRI/MRV), and catheter angiography
People May Experience:
Pain Areas - Nearly 90% of patients suffer from headache
Vision - Vision loss, Diplopia (occurs in about 13% of patients), and papilledema (occurs in about 25% to 30% of patients)
Seizure - Focal or generalized seizure (40%)
Weakness - Focal motor weakness (37%)
Self-care: It is advisable to consult a doctor when experiencing any of the above symptoms.
Medications: Anticoagulants form the cornerstone for the treatment of CSVT. Thrombolytics and endovascular treatment options are also available. Prophylactic anticonvulsants may be considered for seizure prevention in CSVT. 
Specialists: For other concerns, consult a neurologist. At mfine, you will receive a comprehensive knowledge about your disease and its treatment plan required for a healthy life.